3 completed, 2 recruiting, 1 active not recruiting, 1 not yet recruiting. 4 Phase 4, 2 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 3, Not yet recruiting 1 |
| Phase 2 | 2 | Recruiting 2 |
| Phase 3 | 2 | Active not recruiting 1, Recruiting 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow ebastine: new trials by email Literature Review of ebastine trials Research Report on ebastine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ebastine for Adjuvant Treatment of Tumor Budding-Positive Liver Cancer After Surgery Ebastine - Hepato Cellular Carcinoma | Phase 4 | Not yet recruiting | Second Affiliated Hospital of Xi'an Jiaotong University | 45 | 2026-10-01 | 2026-07-29 |
| Effect of Ebastine in Patients With Diarrhea Predominant Irritable Bowel Syndrome ebastine, Placebo - Irritable Bowel Syndrome - Diarrhoea | Phase 2 / Phase 3 | Recruiting | Md. Hazrat Ali | 60 | 2025-08-15 | 2025-08-20 |
| Ebastine in Combination With Docetaxel as a Treatment for Castration-resistant Metastatic Prostate Cancer Docetaxel + Ebastine, Docetaxel - Metastatic Castration-resistant Prostate Cancer | Phase 1 / Phase 2 | Recruiting | Copenhagen University Hospital, Rigshospitalet | 30 | 2024-06-20 | 2025-04-13 |
| Ebastine Versus Mebeverine in IBS Patients Ebastine, Duspatalin - IBS - Irritable Bowel Syndrome, IBS | Phase 3 | Active not recruiting | Guy Boeckxstaens | 200 | 2023-03-30 | 2026-09-11 |
| Peripheral Histamine 1 Receptor Blockade in IBS: Multicenter Trial Ebastine, Placebo - Irritable Bowel Syndrome (IBS) | Phase 4 | Completed | KU Leuven | 200 | 2013-11-01 | 2023-02-08 |
| Evaluation of the Inhibitory Effect of 5 Anti-Histamines in Urticaria Cetirizine, Desloratadine, Fexofenadine - Urticaria | Phase 4 | Completed | Grupo de Alergología Clínica y Experimental | 150 | 2013-08-01 | 2014-02-19 |
| Irritable Bowel Syndrome (IBS) Treatment With H1-receptor Antagonists ebastine, placebo capsule - Irritable Bowel Syndrome | Phase 4 | Completed | KU Leuven | 55 | 2009-10-01 | 2016-01-28 |
Irritable Bowel Syndrome (3) · Urticaria (1)
KU Leuven (2) · Copenhagen University Hospital, Rigshospitalet (1) · Grupo de Alergología Clínica y Experimental (1) · Guy Boeckxstaens (1) · Md. Hazrat Ali (1) · Second Affiliated Hospital of Xi'an Jiaotong University (1)
Belgium (3) · Bangladesh (1) · Colombia (1) · Denmark (1) · Netherlands (1)
Guy Boeckxstaens, M.D. (2) · Guy Boeckxstaens, prof. dr. (1) · Helle Pappot, DMsc (1)
PMID 26752109, PMID 27326985, PMID 28709817, PMID 38191268, PMID 40611014